Rbv Sof published presentations and documents on DocSlides.
Randomisation. Open-label. W8. * Liver biopsy or ...
. PEG alfa-. 2a . versus. INF RBV . APRICOT S...
. with Advanced Liver Disease. ALLY-3+ Study. Phas...
C-WORTHY/D. GZR + EBR + RBV. GZR + EBR + RBV. N =...
ATTAIN. SMV + TVR placebo. + PEG-IFN + RBV. TVR ...
PTV150/r + OBV + . DSV . + RBV. PTV150/r + . DSV...
Last Updated: February . 21, 2014. Robert G. Gish...
Mark Sulkowski, MD . Professor of Medicine. Medic...
Morris Sherman MD . BCh. PhD FRCP(C) . Associate...
-Ritonavir. -Ombitasvir . + Dasabuvir) . + RBV in...
Design. C-SCAPE . Study. : . grazoprevir. ± . e...
Mark S. Sulkowski, MD. Medical Director, Viral He...
OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...
C-WORTHY Study Part C: . grazoprevir. . + . elba...
Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...
*. 1:1. Open-label. ≥ 18 years. HCV genotype ...
Mark Sulkowski, MD. Associate Professor of Medici...
dans les génotypes 1b naïfs de traitement . (1)...
TURQUOISE-II. Phase 3. . Treatment. Naïve and ...
Department of Medicine. University of Toronto. Co...
Design. C-SCAPE . Study. : . grazoprevir. ± . e...
OBV/PTV/r + . DSV . + RBV. OBV/PTV/r + . DSV . + ...
D : . grazoprevir. . + . elbasvir. + RBV in ge...
RBV . versus. . PEG alfa-. 2a . versus. INF + R...
Hepatol. 2016; 64:19-28. MALACHITE. TVR + PEG-IF...
Paritaprevir. -. Ritonavir. . and . Dasabuvir. ...
Feld JJ. NEJM . 2014;370:1594-1603. SAPPHIRE-I . ...
+ . Grazoprevir. +/- Ribavirin in . Treatment-N...
SMV 24W + PEG-IFN + RBV 24-48W **. Randomisation ...
X. J . Hepatology. 2015; 63: 564-72. C-SALVAGE ...
* Liver biopsy or . Fibroscan. ≤. 12.5 . kPa....
Randomisation*. Open-label. >. 18 years. HCV ...
RBV . versus. Interferon alfa. -. 2a + RBV . ACT...
DSV . placebo. Randomisation*. Partial blind. 1...
≥ 18 years. Chronic HCV infection. Genotype 1. ...
Sameh W. Boktor, MD, MPH. Medical Epidemiologist....
treatment. Lisa M. Glass, MD. Clinical Lecturer. ...
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
Gene LeSage, MD, FACP, AGAF. Objectives. HCV epid...
Medical Director, Austin Hepatitis Center. 1. Hep...
Copyright © 2025 DocSlides. All Rights Reserved